These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 1905005)

  • 1. Human Harvey-ras is biochemically different from Kirsten- or N-ras.
    Carbone A; Gusella GL; Radzioch D; Varesio L
    Oncogene; 1991 May; 6(5):731-7. PubMed ID: 1905005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The c-fos proto-oncogene promotor is not regulated by serum, epidermal growth factor, and phorbol ester in embryonal fibroblasts transformed by E1Aad5+cHa-ras-oncogenes].
    Pospelova TV; Medvedev AV; Kisliakova TV; Svetlikova SB; Pospelov VA
    Mol Biol (Mosk); 1991; 25(1):105-15. PubMed ID: 1716733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
    Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
    Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
    Lehtola L; Sistonen L; Koskinen P; Lehväslaiho H; Di Renzo MF; Comoglio PM; Alitalo K
    J Cell Biochem; 1991 Jan; 45(1):69-81. PubMed ID: 1706346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
    Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
    Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential induction of c-fos and c-jun proto-oncogenes and AP-1 activity by tumor promoter 12-O-tetradecanoyl phorbol 13-acetate in cells at different stages of tumor promotion in vitro.
    Wu WS; Lin JK; Wu FY
    Oncogene; 1992 Nov; 7(11):2287-94. PubMed ID: 1437150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in c-myc and c-fos expression in a human tumor cell line following exposure to bifunctional alkylating agents.
    Futscher BW; Erickson LC
    Cancer Res; 1990 Jan; 50(1):62-6. PubMed ID: 2104539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raf revertant cells resist transformation by non-nuclear oncogenes and are deficient in the induction of early response genes by TPA and serum.
    Kolch W; Heidecker G; Troppmair J; Yanagihara K; Bassin RH; Rapp UR
    Oncogene; 1993 Feb; 8(2):361-70. PubMed ID: 8426742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of c-fos and c-jun mRNA expression by basic fibroblast growth factor in cultured rat Müller cells.
    Cao W; Li F; Steinberg RH; LaVail MM
    Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):565-73. PubMed ID: 9501868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation and expression of jun, c-fos and c-myc proto-oncogenes during mouse liver regeneration and after inhibition of protein synthesis.
    Morello D; Lavenu A; Babinet C
    Oncogene; 1990 Oct; 5(10):1511-9. PubMed ID: 2123531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
    Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
    Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-1 signal transduction pathways. I. Two functional IL-1 receptors are expressed in T cells.
    Muñoz E; Zubiaga AM; Sims JE; Huber BT
    J Immunol; 1991 Jan; 146(1):136-43. PubMed ID: 1845804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forskolin and a tumor promoter are able to induce c-fos and c-myc expression in normal, but not in a v-ras-transformed rat thyroid cell line.
    Colletta G; Cirafici AM; Consiglio E; Vecchio G
    Oncogene Res; 1987; 1(4):459-66. PubMed ID: 3329719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum growth factors up-regulate H-ras, K-ras, and N-ras proto-oncogenes in fibroblasts.
    Quincoces AF; León J
    Cell Growth Differ; 1995 Mar; 6(3):271-9. PubMed ID: 7794795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-promoting phorbol ester and activated Ha-ras synergistically reduce the interleukin 3 requirement in a mast cell line.
    Imber R; Fabbro D
    Cancer Res; 1991 Jan; 51(2):632-8. PubMed ID: 1985780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter.
    Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA
    Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.